On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

Report and free match highlights from the Carabao Cup third-round tie between Coventry and Tottenham at the Coventry Building Society Arena on Wednesday night; Late goals from Djed Spence and ...

Plumes of smoke filled the air around a road in Coventry due to a 'significant fire'. Crews from Foleshill and Coventry fire stations raced to the scene in Sydnall Road last night (September 23).

New schizophrenia drug ‘could change the lives of millions of people’ - The US Food and Drug Administration has approved ...

London: Neurocrine Biosciences said on Thursday it will halt the development of its experimental drug, aimed at improving cognitive function in patients with schizophrenia, after it did not ...

A Coventry girl has won the children’s world record for longest hair. Five year old Anastasia Karasjova won the record in July and received her certificate last month, wearing the medal with ...

Officers later found stolen cars, fake documents and drugs. Police said a man was held on Coventry Road after officers spotted a stolen vehicle. It prompted a search at a property where another stolen ...

When a rash broke out on the hand of a patient taking part in the trial of a promising schizophrenia drug, clinical investigator Greg Mattingly began to fret that it might be an allergic reaction.

Neurocrine said it will focus its resources on late-stage development of its other schizophrenia and depression drug candidates. Shares of the company were down 2.5% in extended trading.